Literature DB >> 12588201

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

Yong-Woo Park1, Shankuan Zhu, Latha Palaniappan, Stanley Heshka, Mercedes R Carnethon, Steven B Heymsfield.   

Abstract

BACKGROUND: The metabolic syndrome is an important cluster of coronary heart disease risk factors with common insulin resistance. The extent to which the metabolic syndrome is associated with demographic and potentially modifiable lifestyle factors in the US population is unknown.
METHODS: Metabolic syndrome-associated factors and prevalence, as defined by Adult Treatment Panel III criteria, were evaluated in a representative US sample of 3305 black, 3477 Mexican American, and 5581 white men and nonpregnant or lactating women aged 20 years and older who participated in the cross-sectional Third National Health and Nutrition Examination Survey.
RESULTS: The metabolic syndrome was present in 22.8% and 22.6% of US men and women, respectively (P =.86). The age-specific prevalence was highest in Mexican Americans and lowest in blacks of both sexes. Ethnic differences persisted even after adjusting for age, body mass index, and socioeconomic status. The metabolic syndrome was present in 4.6%, 22.4%, and 59.6% of normal-weight, overweight, and obese men, respectively, and a similar distribution was observed in women. Older age, postmenopausal status, Mexican American ethnicity, higher body mass index, current smoking, low household income, high carbohydrate intake, no alcohol consumption, and physical inactivity were associated with increased odds of the metabolic syndrome.
CONCLUSIONS: The metabolic syndrome is present in more than 20% of the US adult population; varies substantially by ethnicity even after adjusting for body mass index, age, socioeconomic status, and other predictor variables; and is associated with several potentially modifiable lifestyle factors. Identification and clinical management of this high-risk group is an important aspect of coronary heart disease prevention.

Entities:  

Mesh:

Year:  2003        PMID: 12588201      PMCID: PMC3146257          DOI: 10.1001/archinte.163.4.427

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  57 in total

Review 1.  Noninsulin-dependent diabetes mellitus in black and white Americans.

Authors:  M I Harris
Journal:  Diabetes Metab Rev       Date:  1990-03

2.  Prospective analysis of the insulin-resistance syndrome (syndrome X).

Authors:  S M Haffner; R A Valdez; H P Hazuda; B D Mitchell; P A Morales; M P Stern
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

3.  Quantification of adipose tissue by MRI: relationship with anthropometric variables.

Authors:  R Ross; L Léger; D Morris; J de Guise; R Guardo
Journal:  J Appl Physiol (1985)       Date:  1992-02

Review 4.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

Review 5.  Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.

Authors:  R A DeFronzo; E Ferrannini
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

6.  Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.

Authors:  S M Haffner; E Ferrannini; H P Hazuda; M P Stern
Journal:  Hypertension       Date:  1992-07       Impact factor: 10.190

7.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

8.  Smoking induces insulin resistance--a potential link with the insulin resistance syndrome.

Authors:  S Attvall; J Fowelin; I Lager; H Von Schenck; U Smith
Journal:  J Intern Med       Date:  1993-04       Impact factor: 8.989

9.  Nutrient intakes of different social-class groups: results from the Scottish Heart Health Study (SHHS).

Authors:  C Bolton-Smith; W C Smith; M Woodward; H Tunstall-Pedoe
Journal:  Br J Nutr       Date:  1991-05       Impact factor: 3.718

10.  Racial differences in the relation between blood pressure and insulin resistance.

Authors:  M F Saad; S Lillioja; B L Nyomba; C Castillo; R Ferraro; M De Gregorio; E Ravussin; W C Knowler; P H Bennett; B V Howard
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245

View more
  591 in total

1.  Metabolic syndrome is associated with exposure to organochlorine pesticides in Anniston, AL, United States.

Authors:  Paula F Rosenbaum; Ruth S Weinstock; Allen E Silverstone; Andreas Sjödin; Marian Pavuk
Journal:  Environ Int       Date:  2017-08-02       Impact factor: 9.621

2.  Adipokine concentrations in nonobese women: a study of reproductive aging, body mass index, and menstrual cycle effects.

Authors:  Patricia A Rouen; Jane L Lukacs; Nancy E Reame
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

3.  Distribution and correlates of the metabolic syndrome in adults living in the San Juan Metropolitan Area of Puerto Rico.

Authors:  Cynthia M Pérez; Ana P Ortiz; Manuel Guzmán; Erick Suárez
Journal:  P R Health Sci J       Date:  2012-09       Impact factor: 0.705

4.  Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.

Authors:  L M Steffen; M Cushman; J M Peacock; S R Heckbert; D R Jacobs; W D Rosamond; A R Folsom
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

5.  Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy.

Authors:  Keith C Ferdinand
Journal:  Cardiorenal Med       Date:  2012-10-26       Impact factor: 2.041

6.  Lifestyle Intervention for People With Severe Obesity and Serious Mental Illness.

Authors:  John A Naslund; Kelly A Aschbrenner; Emily A Scherer; Sarah I Pratt; Rosemarie S Wolfe; Stephen J Bartels
Journal:  Am J Prev Med       Date:  2015-09-16       Impact factor: 5.043

Review 7.  Drospirenone, a new progestogen, for postmenopausal women with hypertension.

Authors:  Madhavi Mallareddy; Vladimir Hanes; William B White
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome.

Authors:  Elizabeth Stein; Harvey Kushner; Samuel Gidding; Bonita Falkner
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

9.  Genetic control of lipids in the mouse cross DU6i x DBA/2.

Authors:  Gudrun A Brockmann; Ersin Karatayli; Christina Neuschl; Ioannis M Stylianou; Soner Aksu; Antje Ludwig; Ulla Renne; Chris S Haley; Sara Knott
Journal:  Mamm Genome       Date:  2007-11-08       Impact factor: 2.957

Review 10.  Hypertension in black patients: special issues and considerations.

Authors:  Shawna D Nesbitt
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.